Hebrew
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Reduction of the Metabolic Syndrome in Navarra-Spain

רק משתמשים רשומים יכולים לתרגם מאמרים
התחבר הרשם
הקישור נשמר בלוח
סטָטוּסהושלם
נותני חסות
Clinica Universidad de Navarra, Universidad de Navarra
משתפי פעולה
Hospital of Navarra

מילות מפתח

תַקצִיר

The purpose of this study is to determine whether a dietary pattern based on crononutrition and dietary training, together with dietary and psychological control, can reduce the body weight, improve the oxidative and inflammatory state in subjects with diagnosed metabolic syndrome features and can reduce the prevalence of the Metabolic syndrome in the population.

תיאור

The dietary pattern that characterizes the present nutritional intervention study is based on personalized diet, by elaborating tailoring-diets for each subject regarding his energetic needs and assuring a high adherence to the Mediterranean Diet. Moreover, the diet to be performed will be a hyperproteic diet to guarantee a satiety effect and a lower recovery of the lost weight, in accordance with the results derived from the main European study about nutrition (DIOGENES). The glycemic index/load will be also controlled in the study diet. The increase of the antioxidant capacity of the diet will be increased by the intake of fruits, walnuts and virgin olive oil among other antioxidant containing foods.

The present initiative, based on the traditional diet, aims to integrate the main results obtained from diverse observational epidemiological studies and interventional studies in the dietary pattern of the present study. At the same time, the study will apply the concept of crononutrition by selecting and distributing the foods thorough the day according the physiological needs of each individual.

In addition to the quantitative and qualitative composition of the diet, the study will take into account other important factors such as the behavior habits regarding the food, the frequency of consumption, the size of the eating portions, the distribution of the portions along the day, the feeling of fullness, the eating speed and so on. The aforementioned factors have recently been shown to be related to the gain of weight.

Other non dietary factors, such as smoking habits, sedentary life, socio-economic level, will be also controlled in the present study. Moreover, the project will integrate the dietary support together with psychological support due to the fact that the state of mind has been shown to be associated with the MS in some scientific publications.

תאריכים

אומת לאחרונה: 10/31/2011
הוגש לראשונה: 03/10/2010
ההרשמה המשוערת הוגשה: 03/11/2010
פורסם לראשונה: 03/14/2010
העדכון האחרון הוגש: 05/10/2016
עדכון אחרון פורסם: 05/11/2016
תאריך תחילת לימוד בפועל: 12/31/2009
תאריך סיום משוער משוער: 11/30/2010
תאריך סיום משוער ללימודים: 10/31/2011

מצב או מחלה

Metabolic Syndrome
Obesity
Diabetes
Cardiovascular Disease

התערבות / טיפול

Behavioral: Crononutrition

Behavioral: American Heart Association

שלב

-

קבוצות זרועות

זְרוֹעַהתערבות / טיפול
Experimental: Crononutrition
Dietary pattern: Personalized diet Caloric restriction (-30% Total energy intake) High adherence to the Mediterranean Diet Macronutrient distribution (30% Protein, 40% Carbohydrates and 30% Fat) Low glycemic index/load Increased antioxidant capacity of the diet
Behavioral: Crononutrition
After the recruitment and selection of the study participants, the study will consists of a 2-month nutritional intervention (Crononutrition versus AHA) followed by second 6-month period ("autonomy phase") in which the subjects of the study will continue with their ruled dietary patterns, but without any dietary or psychological support.
Placebo Comparator: American Heart Association
Dietary pattern: Personalized diet Caloric diet (-30% Total energy intake) Macronutrients distribution according to the American Heart Association (AHA) guidelines
Behavioral: American Heart Association
After the recruitment and selection of the study participants, the study will consists of a 2-month nutritional intervention (Crononutrition versus AHA) followed by second 6-month period ("autonomy phase") in which the subjects of the study will continue with their ruled dietary patterns, but without any dietary or psychological support.

קריטריונים לזכאות

גילאים הזכאים ללימודים 35 Years ל 35 Years
מינים הזכאים ללימודיםAll
מקבל מתנדבים בריאיםכן
קריטריונים

Inclusion Criteria:

- 35-70 years old

- Both sexes: Male and Female

- Metabolic Syndrome according to the IDF(2005)criteria:

Waist circumference cutoffs (male ≥94 cm or female ≥80 cm) plus any two of the following four factors:

1. Fasting glucose ≥5.55 mmol/L or use of antidiabetic medication

2. Systolic BP ≥130 mm Hg, diastolic BP ≥85 mm Hg, or use of antihypertensive medication

3. Fasting triglycerides ≥1.7 mm/L; and HDL-C <1.0 mm/L in men and <1.3 mm/L in women or specific treatment for this lipid abnormality

Exclusion Criteria:

- Recent follow-up of diets designed for weight loss

- Unstable weight in the past 3 months

- Alcoholic and drug dependence

- Hormonal treatment

- No stable pharmacological treatment

- Eating-disordered behaviors

- Severe physical or mental disability

- Pregnancy

- Terminal disease

- Institutionalization

תוֹצָאָה

מדדי תוצאות ראשוניים

1. Body fat [One year]

Through this specific nutritional intervention program we will try to reduce the metabolic syndrome features such as waist circumference, body weight and adiposity. To evaluate the body composition, bioimpedance, DEXA and anthropometry methodology will be used at the beginning and after two months of intervention.

2. Lipid profile [One year]

To evaluate lipid improvements the following measurements will be taking into account: Free fatty acids Total cholesterol HDL-cholesterol LDL-cholesterol

3. Glucose Profile [One year]

To evaluate glucose improvements the following measurements will be taking into account: Glucose Insulin HOMA

אמצעי תוצאה משניים

1. Inflammation state [One year]

As secondary outcome some inflammatory markers will be analyzed: CRP IL-6 TNF-alpha IL-18 PAI-1 Homocystein

2. Oxidative stress [One year]

As secondary outcome some oxidative stress markers will be analyzed: MDA LDL-OX Total antioxidant capacity (TAC)

3. Psychological tests [January 2010-November 2011]

Beck Depression Inventory Stai Trait Anxiety Inventory Mood thermometer visual analogue scale Anxiety thermometer visual analogue scale NEO personality inventory-revised test

4. Peripheral neurotransmitters [March-April 2013]

Dopamine Dopac Serotonin 5-Hydroxyindoleacetic acid Noradrenaline

5. Epigenetics [April 2012-July 2014]

DNA methylation microRNAs expression

6. Fatty Liver biomarkers / Non invasive liver scoring system. [May 2016- January 2017]

Measurements in fatty liver biomarkers: Serum transaminases (AST & ALT (U/L)), GGT (U/L) and CK18 (U/L) concentrations will be measured in a fasting state at the beginning, at 2 months and at the end of the intervention. - A specificif Fatty Liver Index was calculated at the begining, at 2 months and at the end of the intervention.

הצטרפו לדף הפייסבוק שלנו

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע

  • עובד ב 55 שפות
  • מרפא צמחי מרפא מגובה על ידי מדע
  • זיהוי עשבי תיבול על ידי דימוי
  • מפת GPS אינטראקטיבית - תייגו עשבי תיבול במיקום (בקרוב)
  • קרא פרסומים מדעיים הקשורים לחיפוש שלך
  • חפש עשבי מרפא על פי השפעותיהם
  • ארגן את תחומי העניין שלך והתעדכן במחקר החדשות, הניסויים הקליניים והפטנטים

הקלד סימפטום או מחלה וקרא על צמחי מרפא שעשויים לעזור, הקלד עשב וראה מחלות ותסמינים שהוא משמש נגד.
* כל המידע מבוסס על מחקר מדעי שפורסם

Google Play badgeApp Store badge